Congenital CMV: Difference between revisions
From IDWiki
(→�) |
m (→�: semantic links) |
||
| Line 10: | Line 10: | ||
* Mother may have had asymptomatic infection |
* Mother may have had asymptomatic infection |
||
* At birth |
* At birth |
||
** Microcephaly |
** [[Causes::Microcephaly]] |
||
** Periventricular calcifications |
** [[Causes::Periventricular calcifications]] |
||
** Chorioretinitis |
** [[Causes::Chorioretinitis]] |
||
** Sensorineural hearing loss |
** [[Causes::Sensorineural hearing loss]] |
||
** Optic nerve atrophy |
** [[Causes::Optic nerve atrophy]] |
||
** Hepatosplenomegaly |
** [[Causes::Hepatosplenomegaly]] |
||
** [[Causes::Cytopenias]] |
|||
** Cytopenia |
|||
* Later |
* Later |
||
** Cognitive deficits (7%) |
** [[Causes::Cognitive deficits]] (7%) |
||
** Sensorineural hearing loss (20%) |
** [[Causes::Sensorineural hearing loss]] (20%) |
||
== Diagnosis == |
== Diagnosis == |
||
Revision as of 15:07, 8 February 2020
Epidemiology
- Risk of transmission to fetus
- Primary infection: 30% risk of congenital CMV; higher risk later in pregnancy, but worse outcomes earlier
- Non-primary
- Reinfection: 5% risk
- Reactivation: 1% risk
Clinical Presentation
- Mother may have had asymptomatic infection
- At birth
- Later
- Cognitive deficits (7%)
- Sensorineural hearing loss (20%)
Diagnosis
- In mom, IgM antibodies
- In baby, urine PCR within 2 weeks of birth
Management
- Treatment is indicated for symptomatic babies
- Brain
- Hearing
- Eye
- IV ganciclovir or PO valganciclovir, for 6 months
- Monitor CBC while on therapy
